TxCell Company
TxCell develops cell-based immuno-therapies for the treatment of severe chronic inflammatory diseases.
Industry:
PharmTech
Technology:
Anti-infective Drugs
Funding Status:
M&A
Estimated Revenue:
Less than $1M
Investors Number:
1
Headquarters:
Valbonne, Provence-Alpes-Cote d'Azur, France
Employee Number:
51-100
Investor Type:
For Profit
Total Funding:
$6.3M
Founded Date:
2001-01-01
Last Funding Type:
Debt Financing